These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 25353664)

  • 1. Non-alcoholic fatty liver disease in children: focus on nutritional interventions.
    Yang M; Gong S; Ye SQ; Lyman B; Geng L; Chen P; Li DY
    Nutrients; 2014 Oct; 6(11):4691-705. PubMed ID: 25353664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of nutrition in non-alcoholic fatty liver disease treatment in obese children.
    Guimber D; Debray D; Bocquet A; Briend A; Chouraqui JP; Darmaun D; Feillet F; Frelut ML; Hankard R; Lapillonne A; Peretti N; Rozé JC; Simeoni U; Turck D; Dupont C; Comité de Nutrition de la Société Française de Pédiatrie Cnsfp
    Arch Pediatr; 2022 Jan; 29(1):1-11. PubMed ID: 34758930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease.
    Hernandez-Rodas MC; Valenzuela R; Videla LA
    Int J Mol Sci; 2015 Oct; 16(10):25168-98. PubMed ID: 26512643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence.
    Cicero AFG; Colletti A; Bellentani S
    Nutrients; 2018 Aug; 10(9):. PubMed ID: 30142943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota, Fiber, and NAFLD: Is There Any Connection?
    Pérez-Montes de Oca A; Julián MT; Ramos A; Puig-Domingo M; Alonso N
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33053631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol.
    Lambert JE; Parnell JA; Eksteen B; Raman M; Bomhof MR; Rioux KP; Madsen KL; Reimer RA
    BMC Gastroenterol; 2015 Dec; 15():169. PubMed ID: 26635079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fructose, Omega 3 Fatty Acids, and Vitamin E: Involvement in Pediatric Non-Alcoholic Fatty Liver Disease.
    Alberti G; Gana JC; Santos JL
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33212947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of diet and nutritional management in non-alcoholic fatty liver disease.
    Fan JG; Cao HX
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():81-7. PubMed ID: 24251710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children.
    Africa JA; Newton KP; Schwimmer JB
    Dig Dis Sci; 2016 May; 61(5):1375-86. PubMed ID: 27041377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 Fatty Acids and Fatty Liver Disease in Children.
    Corte CD; Iasevoli S; Strologo AD; Sanseviero M; Nobili V
    Adv Food Nutr Res; 2018; 85():59-77. PubMed ID: 29860977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease in obese children and adolescents: a role for nutrition?
    Bonsembiante L; Targher G; Maffeis C
    Eur J Clin Nutr; 2022 Jan; 76(1):28-39. PubMed ID: 34006994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver disease.
    Simopoulos AP
    Nutrients; 2013 Jul; 5(8):2901-23. PubMed ID: 23896654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease.
    Koopman N; Molinaro A; Nieuwdorp M; Holleboom AG
    Aliment Pharmacol Ther; 2019 Sep; 50(6):628-639. PubMed ID: 31373710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease.
    Tarantino G; Finelli C
    Future Microbiol; 2015; 10(5):889-902. PubMed ID: 26000656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics Supplemented with Omega-3 Fatty Acids are More Effective for Hepatic Steatosis Reduction in an Animal Model of Obesity.
    Kobyliak N; Falalyeyeva T; Bodnar P; Beregova T
    Probiotics Antimicrob Proteins; 2017 Jun; 9(2):123-130. PubMed ID: 27660157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Gut Microbiota and Its Metabolites, Novel Targets for Treating and Preventing Non-Alcoholic Fatty Liver Disease.
    Ni Y; Ni L; Zhuge F; Fu Z
    Mol Nutr Food Res; 2020 Sep; 64(17):e2000375. PubMed ID: 32738185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease.
    Eslamparast T; Tandon P; Raman M
    Nutrients; 2017 Jul; 9(8):. PubMed ID: 28933748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Molecular and Mechanistic Insights Based on Gut-Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement.
    Ji Y; Yin Y; Sun L; Zhang W
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern.
    Nier A; Brandt A; Conzelmann IB; Özel Y; Bergheim I
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30235828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.